1. Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab. (December 2016) Authors: Iida, M.; Bahrar, H.; Brand, T.; Pearson, H.; Coan, J.; Orbuch, R.; Flanigan, B.; Swick, A.; Prabakaran, P.; Lantto, J.; Horak, I.; Kragh, M.; Salgia, R.; Kimple, R.; Wheeler, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗